A high-stakes corporate battle over one of Europe’s better-known chipmakers is intensifying after China’s Wingtech said it will “exhaust all legal means” to regain full control of Nexperia, the Netherlands-based semiconductor firm it owns.
Wingtech’s pledge came in a filing to the Shanghai Stock Exchange on Wednesday, after a Dutch court ordered a formal investigation into allegations of mismanagement at Nexperia BV and upheld earlier measures that limit the parent’s influence over the business. In the filing, Wingtech said its control over Nexperia “remains restricted” and signalled it would keep fighting the court-backed governance changes.
The case has become a proxy for broader anxiety in Europe about strategic industries and supply-chain security, while also exposing the practical strain that can follow when an internationally owned manufacturer is pulled into a national-interest dispute. Nexperia is a key supplier of semiconductors used across consumer electronics and industrial applications, and it has long-standing relationships with customers that rely on predictable production and delivery schedules.
The Dutch court’s decision, delivered earlier the same day, ordered an investigation into alleged mismanagement and maintained an October ruling that suspended then-chief executive Zhang Xuezheng, who is also the founder of Wingtech. The court, in supporting those earlier steps, effectively kept day-to-day control with the European management team and continued to ring-fence governance decisions from the Chinese parent while the inquiry proceeds.
In practical terms, that means Wingtech can own Nexperia on paper yet still find itself unable to steer the company as it normally would — a rare and commercially uncomfortable position for any controlling shareholder. Wingtech’s latest statement makes clear it views the restrictions as temporary and contestable, and it is preparing to challenge them through further legal action.
At the centre of the dispute is a breakdown in trust between Nexperia’s European executives and Wingtech’s leadership, with the European side pushing for outside scrutiny of how the company was run and the Chinese owner insisting its authority should be restored. The court-ordered investigation is intended to examine whether mismanagement occurred and whether governance at the firm needs deeper reform. Investigations of this kind can be extensive, drawing in documents, board minutes, internal communications and testimony from current and former executives.
For customers and suppliers, the stakes are less about courtroom drama and more about operational certainty. Semiconductor supply chains are complex, and even a modest disruption in decision-making — such as delays in approving capacity plans, procurement, or investment — can ripple outward. In recent years, automakers and industrial manufacturers have been particularly sensitive to chip bottlenecks, and any hint of instability at a key supplier can quickly become a commercial concern.
The legal fight also highlights a growing trend: ownership and control are no longer treated as the same thing when governments or courts conclude that strategic risks might be at play. In Europe, scrutiny has increased around critical infrastructure and technologies, including semiconductors, as policymakers try to reduce exposure to geopolitical shocks. Company boards and investors, meanwhile, are being forced to price in a new category of risk — not just market cycles and competition, but regulatory and governance interventions that can abruptly change who gets to make decisions.
Wingtech did not outline specific next steps in its exchange filing, but its language strongly suggests it is preparing for a prolonged contest. If the restrictions remain in place while the investigation runs, Nexperia may have to operate in a “stabilise first” mode, focusing on internal cohesion and continuity with customers, rather than major strategic shifts.
What happens next will likely be shaped by the investigation’s scope and pace, and by whether courts maintain the view that stability at the company requires limiting the parent’s direct influence. For now, Wingtech has chosen its message carefully: it is not backing down, and it is treating the fight for control of Nexperia as a matter to be decided in courtrooms and filings — not boardrooms.
The latest developments were reported by Reuters.
